Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Clinical trial NCT00070096 · COMPLETED

Trial details

NCT number: NCT00070096
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Testicular Germ Cell Tumor

Start date: 2003-08-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.